You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. METAGENOMI INC.

Metagenomi Inc. XNAS: MGX

Metagenomi Inc. Live Share Price Today, Share Analysis and Chart

Weak Stock
Download real time

1.52 0.04 (2.70%)

81.90% Fall from 52W High

329.0K XNAS Volume

XNAS 17 Apr, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
Board Meeting
The next board meeting for Metagenomi Inc. is on 30 Apr 2025 for the purpose of Metagenomi Inc Annual General Meeting for 2024 See details

Metagenomi Inc. Key Metrics

Default

Market Capitalization

Below industry Median
56.8

PE TTM

Negative PE TTM
-0.7

PEG TTM

Below industry Median
0.1

Price to Book

Low in industry
0.2

Institutional holding current Qtr %

Below industry Median
28.4

Revenue Growth Qtr YoY %

Negative Revenue Growth Qtr YoY %
-22.5

Operating Revenue growth TTM %

Below industry Median
16.8

Net Profit Qtr Growth YoY %

Negative Net Profit Qtr Growth YoY %
-21.3

Net Profit TTM Growth %

Negative Net Profit TTM Growth %
-14.4

Operating Profit Margin Qtr %

Negative Operating Profit Margin Qtr %
-214.5

Operating Profit Margin TTM %

Negative Operating Profit Margin TTM %
-170

Piotroski Score

Below industry Median
2

Rel Perf vs Sector quarter%

-40.8

ROE Annual %

Negative ROE Annual %
-157.3

RoA Annual %

Negative RoA Annual %
-22.6
All financials are in USD Million and price data in USD
VIEW MORE
Durability score
Low Financial Strength
11.1 / 100
Valuation Score
Expensive Valuation
29.3 / 100
Momentum Score
Technically Bearish
31.0 / 100
Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
16
1Yr Price target upside is 926%
5 analysts

8

S

19

W

4

O

1

T

SWOT Analysis

Check P/E Buy Sell Zone

This stock has negative PE


Metagenomi Inc. Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '23Dec '24Dec '25Dec '26050100Actual RevenueAvg. Estimate
Hit

Metagenomi Inc.'s Revenue was higher than average estimate 2 times in past 2 years

EPS forecast

Current EPS
-2.4
Avg. Estimate
-2.4
Low Estimate
-3.6
High Estimate
-1.5
Current EPS
Avg. Estimate
Miss

EPS is expected to reduce by 2.1% in FY25

Consensus Recommendation

7 ANALYST Recommendations
BUY

Created with Highcharts 7.2.21Hold2Buy4Strong Buy

The consensus recommendation from 7 analysts for Metagenomi Inc. is BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Metagenomi Inc. Stock Analysis

Metagenomi Inc. stock analysis with key metrics, changes, and trends.

Metagenomi Inc. MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$52.3 M16.84%positive

Annual Revenue rose 16.84%, in the last year to $52.3 M. Its sector's average revenue growth for the last fiscal year was 7.54%.

Annual Net Profit$78.06 M14.36%negative

Annual Net Profit fell 14.36% in the last year to $78.06 M. Its sector's average net profit growth for the last fiscal year was -30.36%.

Price to Earning Ratio-0.73-negative

Price to Earning Ratio is -0.73, which is negative.

Stock Price$1.52-77.94%negative

Stock Price fell 77.94% and underperformed its sector by 85.27% in the past year.

Quarterly Revenue$9.61 M22.46%negative

Quarterly Revenue fell 22.46% YoY to $9.61 M. Its sector's average revenue growth YoY for the quarter was 5.84%.

Quarterly Net profit$23.4 M21.27%negative

Quarterly Net profit fell 21.27% YoY to $23.4 M. Its sector's average net profit growth YoY for the quarter was -48.37%.

Debt to Equity Ratio0.19-positive

Debt to Equity Ratio of 0.19 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE)-157.26 %-157.26%negative

Return on Equity(ROE) for the last financial year was -157.26%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding12.86 %0.05%positive

Mutual Fund Holding increased by 0.05% in the last quarter to 12.86.

Institutional Holding28.41 %-0.13%negative

Institutional Holding decreased by 0.13% in the last quarter to 28.41.

VIEW LESS


Loading data..

Metagenomi Inc. - Company Profile

What does Metagenomi Inc. do?

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.

Metagenomi Inc. Management structure

All Gross Remunerations are in USD
Dr. Brian C. Thomas, PhD
Chief Executive Officer and Chairman of the Board
6.06 M
2024
Gross Remuneration
Year
Dr. Jian Irish, M.B.A.,PhD
President, Chief Operating Officer and Director
3.78 M
2024
Gross Remuneration
Year
Ms. Pamela Wapnick, M.B.A.
Chief Financial Officer and Principal Accounting Officer
3.58 M
2024
Gross Remuneration
Year
Dr. Luis G. Borges, PhD
Chief Scientific Officer
-
2024
Gross Remuneration
Year
Dr. Sarah B. Noonberg, M.D.,PhD
Chief Medical Officer
-
2024
Gross Remuneration
Year
Mr. Simon Harnest, M. Sc.
Chief Investment Officer and Senior Vice President of Strategy
-
2024
Gross Remuneration
Year

Metagenomi Inc. Board of directors

All Gross Remunerations are in USD
Mr. Eric H. Bjerkholt
Independent Director
-
2025
Gross Remuneration
Year

Metagenomi Inc. FAQ

How is Metagenomi Inc. today?
Metagenomi Inc. today is trading in the green, and is up by 2.70% at 1.52.
Metagenomi Inc. is currently trading up 2.70% on an intraday basis. In the past week the stock rose 2.70%. stock has been down -41.76% in the past quarter and fell -77.94% in the past year. You can view this in the overview section.